Literature DB >> 2547996

Identification and characterization of a human cytomegalovirus gene coding for a membrane protein that is conserved among human herpesviruses.

R Lehner1, H Meyer, M Mach.   

Abstract

A rabbit antiserum was raised against envelope material from purified human cytomegalovirus strain AD169. The serum recognized polypeptides 200, 170, 160, 75, 58, and 45 kilodaltons in size. It was used to screen a cDNA library constructed from poly(A)+ RNA from human cytomegalovirus-infected cells in the expression vector lambda gt11. A recombinant bacteriophage expressing cytomegalovirus-specific sequences was identified, and the corresponding gene was mapped to the HindIII R fragment. The gene is transcribed into a late 1.5-kilobase RNA. The nucleotide sequence of the coding region was determined. Computer analysis of the gene product revealed a polypeptide containing multiple potential membrane-spanning domains, representing a type of protein not identified in the envelope of herpesviruses before. The protein shows homology on the amino acid level to hypothetical proteins from reading frames BBRF3 of Epstein-Barr virus, UL10 of herpes simplex virus type 1, and ORF50 of varicella-zoster virus. By using an antiserum raised against procaryote-expressed parts of the cytomegalovirus membrane protein, a 45-kilodalton structural component of the virus was identified as the gene product.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547996      PMCID: PMC250972          DOI: 10.1128/JVI.63.9.3792-3800.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus.

Authors:  M F Stinski
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

2.  Structural components of human cytomegalovirus: in situ localization of the major glycoprotein.

Authors:  M P Landini; B Severi; L Badiali; E Gonczol; G Mirolo
Journal:  Intervirology       Date:  1987       Impact factor: 1.763

3.  A fast and simple method for sequencing DNA cloned in the single-stranded bacteriophage M13.

Authors:  P H Schreier; R Cortese
Journal:  J Mol Biol       Date:  1979-03-25       Impact factor: 5.469

4.  Nonviral microbodies with viral antigenicity produced in cytomegalovirus-infected cells.

Authors:  J E Craighead; R E Kanich; J D Almeida
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

7.  The hydrophobic effect and the organization of living matter.

Authors:  C Tanford
Journal:  Science       Date:  1978-06-02       Impact factor: 47.728

8.  Human cytomegalovirus: purification of enveloped virions and dense bodies.

Authors:  P Talbot; J D Almeida
Journal:  J Gen Virol       Date:  1977-08       Impact factor: 3.891

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Human cytomegalovirus: glycoproteins associated with virions and dense bodies.

Authors:  M F Stinski
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

View more
  33 in total

1.  Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes.

Authors:  U Hobom; W Brune; M Messerle; G Hahn; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).

Authors:  M Mach; B Kropff; P Dal Monte; W Britt
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.

Authors:  B Wagner; B Kropff; H Kalbacher; W Britt; V A Sundqvist; L Ostberg; M Mach
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  The carboxy-terminal domain of glycoprotein N of human cytomegalovirus is required for virion morphogenesis.

Authors:  Michael Mach; Karolina Osinski; Barbara Kropff; Ursula Schloetzer-Schrehardt; Magdalena Krzyzaniak; William Britt
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

5.  The open reading frames UL3, UL4, UL10, and UL16 are dispensable for the replication of herpes simplex virus 1 in cell culture.

Authors:  J D Baines; B Roizman
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding.

Authors:  M A Billstrom; W J Britt
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Identification and characterization of a novel structural glycoprotein in pseudorabies virus, gL.

Authors:  B G Klupp; J Baumeister; A Karger; N Visser; T C Mettenleiter
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Human cytomegalovirus UL76 encodes a novel virion-associated protein that is able to inhibit viral replication.

Authors:  Shang-Kwei Wang; Chang-Yih Duh; Cheng-Wen Wu
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Characterization of a human cytomegalovirus 1.6-kilobase late mRNA and identification of its putative protein product.

Authors:  R S Lahijani; E W Otteson; J D Adlish; S C St Jeor
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

10.  The equine herpesvirus 1 glycoprotein gp21/22a, the herpes simplex virus type 1 gM homolog, is involved in virus penetration and cell-to-cell spread of virions.

Authors:  N Osterrieder; A Neubauer; C Brandmuller; B Braun; O R Kaaden; J D Baines
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.